Safety studies regarding a standardized extract of fermented wheat germ

International Journal of Toxicology

Volumn 26, Issue 3, 2007, Pages 253-259

  Heimbach, James T ^a   Sebestyen, Gyula ^b   Semjen, Gabor ^c   Kennepohl, Elke ^d  

^a JHeimbach LLC   (United States)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c SZENT ISTVÁN UNIVERSITY   (Hungary)

^d Write Tox Consulting   (Canada)

Author keywords

Avemar pulvis; Dietary Supplement; DMBQ; Fermented Wheat Germ; Safety; Toxicity

Indexed keywords

AVEMAR PULVIS; BENZOQUINONE DERIVATIVE; MALTODEXTRIN; PLANT EXTRACT; SILICON DIOXIDE; UNCLASSIFIED DRUG; WHEAT GERM EXTRACT;

ANIMAL EXPERIMENT; ARTICLE; CANCER; CHEMOTHERAPY; CONTROLLED STUDY; DIET SUPPLEMENTATION; FERMENTED PRODUCT; GENOTOXICITY; MOUSE; MUTAGENICITY; NONHUMAN; RAT; SAFETY; TOXICOLOGY; WHEAT GERM;

ANIMALS; ANTICARCINOGENIC AGENTS; BENZOQUINONES; CHO CELLS; CLINICAL TRIALS AS TOPIC; CONSUMER PRODUCT SAFETY; CRICETINAE; CRICETULUS; DIETARY SUPPLEMENTS; DNA FRAGMENTATION; FEMALE; LETHAL DOSE 50; MALE; MICE; MICE, INBRED STRAINS; NEOPLASMS; NO-OBSERVED-ADVERSE-EFFECT LEVEL; PLANT EXTRACTS; RATS; RATS, INBRED F344; RATS, WISTAR; TOXICITY TESTS; TRITICUM;

RODENTIA; TRITICUM AESTIVUM;

EID: 34250309936     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1080/10915810701369709     Document Type: Article

References (32)

1. Bahnemann, R., M. Jacobs, E. Karbe, W. Kauffmann, G. Morawietz, T. Nolte, and S. Rittinghausen. 1995. RITA (Registry of Industrial Toxicology Animal data) guides for organ sampling and trimming procedures in rats. Exp. Toxicol. Pathol. 47:247-266.
2. Balint, G., A. Apathy, M. Gaal, A. Telekes, A. Resetar, G. Blazso, G. Falkay, B. Szende, A. Paksy, M. Ehrenfeld, Y. Shoenfeld, and M. Hidvegi. 2006. Effect of Avemar - a fermented wheat germ extract - on rheumatoid arthritis. Preliminary data. Clin. Exp. Rheumatol. 24:325-328.
3. Balogh, A. 2001a. Supportive effects of Avemar in breast cancer. In: Development of biotechnologically produced - fermented - wheat germ extract (Avemar) and its use in the supportive therapy of cancer. Biotechnologia 2000. Hungarian Government Grant number OMFB-02440/2000, Budapest, Hungary. [Unpublished report.]
4. Balogh, A. 2001b. Effects of long-term Avemar treatment on quality of life in breast cancer. In Development of biotechnologically produced - fermented - wheat germ extract (Avemar) and its use in the supportive therapy of cancer. Biotechnologia 2000. Hungarian Government Grant number OMFB-02440/2000, Budapest, Hungary. [Unpublished report.]
5. Boros, L. G., M. Nichelatti, and Y. Shoenfeld. 2005. Fermented wheat germ extract (Avemar) in the treatment of cancer and autoimmune diseases. Ann. N. Y. Acad. Sci. 1051:529-542.
6. Brambilla, G., E. Cajelli, M. Mazzei, A. Pino, and L. Robbiano. 1986. Formation of genotoxic products by interaction of dimethophrine with nitrite. Proc. Annu. Meet. Am. Assoc. Cancer Res. 27:105.
7. Brambilla, G., L. Robbiano, E. Cajelli, A. Martelli, F. Turmolini, and M. Mazzei. 1988. Cytotoxic DNA-damaging and mutagenic properties of 2,6 dimethoxy-1,4-benzoquinone formed by dimethophrine-nitrite interaction. J. Pharmacol. Exp. Therapeut. 244:1011-1015.
8. Csik, M. 2000. Genotoxicology analysis of Avemar and azoxymethane in the rat's marrow micro-nucleus test. Expert's Opinion. Report number 016.00.358.MN. Department of Experimental Pathology and Mutagenic Research, National Institute of Chemical Safety, Budapest, Hungary. [Unpublished report.]
9. Csiko, G., G. Semjen, R. Glavits, V. Ratz, and G. Sebestyen. 2000. Subacute oral toxicity study of Avemar with 28-day treatment and 14-day post-treatment period in rat: Final report. University of Veterinary Science, Department of Pharmacology and Toxicology. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
10. Csiko, G., G. Semjen, and V. Ratz. 1999. Acute oral toxicity study of Avemar in rat: Final report. University of Veterinary Science, Department of Pharmacology and Toxicology. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
11. Demidov, L. V., V. Manzjuk, G. Y. Kharkevitch, N. A. Pirogova, and E. V. Artamonova. 2002. Antimetastatic effect of Avemar in high-risk melanoma patients. Interim results of an ongoing study presented at the 18th UICC International Cancer Congress, Oslo, Norway, July. Abstract No. P868. Int. J. Cancer 100(Suppl 13):408.
12. FIP (First Institute of Pathology). 1997. 77 days-long toxicity study of Avemar (M1) in F344 rats and in C57BL/6 mice. Semmelweiss Medical University. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
13. Garami, M., D. Schuler, M. Babosa, G. Borgulya, P. Hauser, J. Muller, A. Paksy, E. Szabo, M. Hidvegi, and G. Fekete. 2004. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J. Pediatr. Hematol. Oncol. 26:631-635.
14. Handa, S. S., A. D. Kinghorn, G. A. Cordell, and N. R. Farnsworth. 1983. Plant anticancer agents. XXVI. Constituents of Peddiea fischeri. J. Nat. Prod. 46:248-250.
15. Hidvegi, M., J. Moldvay, K. Lapis, and Z. Ajkay. 2003. Fermented wheat germ extract improves quality of life in lung cancer patients. (In Hungarian). Medicus Anonymus/Pulmono 11(Suppl 1):13-14.
16. Hidvegi, M., E. Raso, R. T. Farkas, K. Lapis, and B. Szende. 1999. Effect of MSC on the immune response of mice. Immunopharmacology 41:183-186.
17. Hidvegi, M., E. Raso, R. Tomoskozi-Farkas, S. Paku, K. Lapis, and B. Szende. 1998. Effect of Avemar and Avemar+vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 18:2353-2358.
18. Hoffmann, A. 2005. Evaluation of the safety of long-term administration of Avemar on hemostasis in cancer patients. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
19. IPCM (Institute of Preventive and Clinical Medicine). 1999. Acute oral toxicity study of Avemar in rat: Final report. Ministry of Health, Slovakia (Bratislava). [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
20. Jakab, F., Y. Shoenfeld, A. Balogh, M. Nichelatti, A. Hoffmann, Z. Kahan, K. Lapis, A. Mayer, P. Sapy, F. Szentpetery, A. Telekes, L. Thurzo, A. Vagvolgyi, and M. Hidvegi. 2003. A medical nutriment has supportive value in the treatment of colorectal cancer. Br. J. Cancer 89:465-469.
21. Lehel, J., G. Semjen, and V. Ratz. 1999. Acute oral toxicity study of Avemar in mouse: Final report. University of Veterinary Science, Department of Pharmacology and Toxicology. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
22. Mohtashamipur, E., and K. Norpoth. 1984. Non-mutagenicity of some wood-related compounds in the bacterial/microsome plate incorporation and microsuspension assays. Int. Arch. Occup. Environ. Health 54:83-90.
23. Nichelatti, M., and M. Hidvegi. 2002. Experimental and clinical results with Avemar (a dried extract from fermented wheat germ) in animal cancer models and in cancer patients. Nogyogyaszati Onkologia 7:180-185.
24. NICS (National Institute of Chemical Safety). 2004. Chemo-prevention of the toxicity of nickel, and of the mutagenic toxicities of cobalt, urethane and formaldehyde in Drosophila melanogaster by Avemar. Fodor Jozsef National Center of Public Health. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
25. Posner, E. S. 1985. The technology of wheat germ separation in flour mills. Assoc Operative Millers Bull, Suppl 1,2 (October).
26. Sebestyen, G. 2004. Effect of long-lasting adjuvant Avemar treatment on the hematologic status of carcinoma patients. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
27. Sebestyen, G. 2005. Effect of 5-year adjuvant Avemar treatment on the hematologic status of carcinoma patients. Budapest, Hungary. [Unpublished report on file at Biromedicina Corporation, Budapest, Hungary.]
28. Szende, B., Z. Marcsek, Z. Kocsis, and A. Tompa. 2004. Effect of simultaneous administration of Avemar and cytostatic drugs on viability of cell cultures, growth of experimental tumors, and survival of tumor-bearing mice. Cancer Biother. Radiopharm. 19:343-349.
29. Tomoskozi-Farkas, R., and H. G. Daood. 2004. Modification of chromatographic method for the determination of benzoquinones in cereal products. Chromatographia 60:S227-S230.
30. Tsen, C. C. 1985. Amino acid composition and biological value of cereal germs. In: Amino acid composition and biological value of cereal proteins, ed. R. Lásztity and M. Hidvégi, 453-466. Boston: D. Reidel.
31. U.S. Department of Agriculture, Economic Research Service (USDA/ERS). 2005. U.S. per capita food consumption. Available at the USDA/ERS website at http://www.ers.usda.gov/data/foodconsumption/
32. Zalatnai, A., K. Lapis, B. Szende, E. Raso, A. Telekes, A. Resetar, and M. Hidvegi. 2001. Wheat germ extract inhibits experimental colon carcinogenesis in F-344 rats. Carcinogenesis 22:1649-1652.